Chemical activators of NET-5 utilize various cellular pathways to modulate the protein's activity. Forskolin, through its action on adenylate cyclase, elevates cyclic AMP (cAMP) levels within the cell, which in turn activates protein kinase A (PKA). Activated PKA can phosphorylate NET-5, leading to changes in cytoskeletal organization and membrane dynamics, processes in which NET-5 is involved. Similarly, Phorbol 12-myristate 13-acetate (PMA) and 1,2-Dioctanoyl-sn-glycerol (DiC8) function as activators of protein kinase C (PKC). PKC directly phosphorylates NET-5 or alters other proteins in signaling pathways that affect NET-5's role in the cell. The phosphorylation cascade initiated by PMA and DiC8 can result in NET-5's activation, impacting cellular adhesion and motility.
Ionomycin and Thapsigargin increase intracellular calcium concentrations, which in turn can activate calcium-dependent protein kinases that phosphorylate NET-5. This calcium-mediated pathway underscores NET-5's participation in calcium-dependent cellular processes. The growth factors, Epidermal Growth Factor (EGF) engages its receptor and triggers downstream signaling pathways such as the PI3K/Akt and MAPK pathways. This pathway can lead to NET-5 activation through various mechanisms including membrane trafficking and cytoskeletal reorganization. Insulin, through its receptor, similarly engages the PI3K/Akt signaling pathway, influencing glucose transport and membrane dynamics that involve NET-5. Calyculin A and Okadaic Acid, by inhibiting protein phosphatases 1 and 2A, prevent the dephosphorylation of proteins, thereby sustaining or enhancing phosphorylation levels of NET-5, which promotes its activation within the cell. Anisomycin, by activating the MAPK pathway, plays a role in the phosphorylation and subsequent activation of NET-5, aligning with NET-5's function in growth and differentiation. Lastly, Sphingosine-1-phosphate engages with its G-protein-coupled receptors to activate signaling pathways that can influence NET-5's activity related to cytoskeletal rearrangements.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which in turn activates PKA. PKA activation can lead to phosphorylation and activation of NET-5 by affecting the cytoskeletal organization and membrane dynamics that NET-5 is involved in. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC) which can phosphorylate NET-5 directly or influence the signaling pathways that control the cytoskeletal rearrangements, where NET-5 is involved. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin increases intracellular calcium concentration, which can activate calcium-dependent protein kinases that could phosphorylate and activate NET-5, as NET-5 is involved in calcium-dependent cellular processes. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $46.00 $249.00 | 2 | |
DiC8 directly activates PKC, which can phosphorylate and activate NET-5, as NET-5 is associated with signaling pathways that are regulated by PKC such as cellular adhesion and motility. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000C | 10 µg 100 µg 1 mg | $160.00 $750.00 $3000.00 | 59 | |
Calyculin A inhibits protein phosphatases 1 and 2A, leading to increased phosphorylation levels of proteins, which can include NET-5, thereby activating its associated signaling pathways. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases 1 and 2A, which could result in the enhanced phosphorylation and activation of NET-5 within its signaling context. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin activates the MAPK pathway, which could result in the activation of NET-5 due to its involvement in MAPK-related cellular processes such as growth and differentiation. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
Sphingosine-1-phosphate binds to its G-protein-coupled receptors, which could activate NET-5 by influencing signal transduction pathways associated with cytoskeletal rearrangements. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin causes an increase in intracellular calcium levels, which could activate NET-5 through the activation of calcium-dependent signaling pathways and protein kinases. | ||||||